ММВБ 2 437 -0,4%  Nasdaq 11 389 -0,3%  Биткойн 30 316 -0,1%  USD/RUB 62,1250 0,0% 
РТС 1 246 2,7%  S&P500 3 901 -0,6%  Нефть 111,0 -0,4%  EUR/RUB 65,6257 -0,2% 
Dow 31 253 -0,8%  FTSE100 7 303 -1,8%  Золото 1 839 -0,2%  EUR/USD 1,0562 -0,2% 

Crucell N.V. - Профиль

Crucell N.V. is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases. Its vaccines are sold in public and private markets worldwide. Crucell's core portfolio includes a vaccine against hepatitis B, a fully-liquid vaccine against five important childhood diseases and a virosome-adjuvanted vaccine against influenza. Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on the market.

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент